What is Ana Garza Avila's NPI number?

Ana Garza Avila's National Provider Identifier (NPI) is 1871738385, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Ana Garza Avila's specialty?

Ana Garza Avila is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).

Where is Ana Garza Avila located?

Ana Garza Avila's practice location on file with NPPES is 4458 Medical Dr Ste 505, San Antonio, TX 78229-3748.

What is Ana Garza Avila's phone number?

The practice phone number listed in the NPPES registry for Ana Garza Avila is (210) 690-7400.

Does Ana Garza Avila accept Medicare?

Ana Garza Avila is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Ana Garza Avila's NPI active?

Yes — Ana Garza Avila's NPI (1871738385) is active in the NPPES registry as of the last update on 2025-08-12.

IndividualActiveAccepts Medicare

Ana Garza Avila, M.D., MSC

NPI 1871738385 · Pulmonary Disease Physician · San Antonio, TX

Ana Garza Avila, M.D., MSC is a Pulmonary Disease Physician provider in San Antonio, TX (NPI 1871738385).

Provider details

NPI number: 1871738385
Entity type: Individual
Primary specialty: Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
Credential: M.D., MSC
Sex: Female
Sole proprietor: Yes
License: S1401 (TX)

Practice location

4458 Medical Dr Ste 505

San Antonio, TX 78229-3748

Phone: (210) 690-7400

Fax: (210) 690-7405

Street-level locationGet directions

More TX providers

Mailing address

4458 Medical Dr Ste 505

San Antonio, TX 78229-3748

Specialties & taxonomies

Pulmonary Disease PhysicianPrimary207RP1001XLicense S1401 (TX)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Pulmonary Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(78/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
17 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
1,240 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233	471	$111
Critical Care, First 30-74 Minutes99291	414	$203
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	86	$120
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	43	$84
Test to Examine How Well the Lungs Exchange Gases94729	41	$51
Initial Hospital Care With Moderate Level of Medical Decision Making, If Using Time, at Least 75 Minutes99223	39

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 19 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta	77	21
Azithromycin	55	27
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	54	24
Methylprednisolone	43	25
Nintedanib Esylatebrand: Ofev	32	—
Budesonide/Glycopyr/Formoterolbrand: Breztri Aerosphere	30	—
Mepolizumabbrand: Nucala

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$692 across 32 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2008-12-11
Last updated: 2025-08-12
Certified: 2025-08-12

Frequently asked questions

What is Ana Garza Avila's NPI number?: Ana Garza Avila's National Provider Identifier (NPI) is 1871738385, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Ana Garza Avila's specialty?: Ana Garza Avila is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).
Where is Ana Garza Avila located?: Ana Garza Avila's practice location on file with NPPES is 4458 Medical Dr Ste 505, San Antonio, TX 78229-3748.
What is Ana Garza Avila's phone number?: The practice phone number listed in the NPPES registry for Ana Garza Avila is (210) 690-7400.
Does Ana Garza Avila accept Medicare?: Ana Garza Avila is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Ana Garza Avila's NPI active?: Yes — Ana Garza Avila's NPI (1871738385) is active in the NPPES registry as of the last update on 2025-08-12.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233	471	$111
Critical Care, First 30-74 Minutes99291	414	$203
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	86	$120
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	43	$84
Test to Examine How Well the Lungs Exchange Gases94729	41	$51
Initial Hospital Care With Moderate Level of Medical Decision Making, If Using Time, at Least 75 Minutes99223	39

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 19 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta	77	21
Azithromycin	55	27
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	54	24
Methylprednisolone	43	25
Nintedanib Esylatebrand: Ofev	32	—
Budesonide/Glycopyr/Formoterolbrand: Breztri Aerosphere	30	—
Mepolizumabbrand: Nucala

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$692 across 32 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments